1. Home
  2. CTMX vs PHUN Comparison

CTMX vs PHUN Comparison

Compare CTMX & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • PHUN
  • Stock Information
  • Founded
  • CTMX 2008
  • PHUN 2009
  • Country
  • CTMX United States
  • PHUN United States
  • Employees
  • CTMX N/A
  • PHUN N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • PHUN EDP Services
  • Sector
  • CTMX Health Care
  • PHUN Technology
  • Exchange
  • CTMX Nasdaq
  • PHUN Nasdaq
  • Market Cap
  • CTMX 85.3M
  • PHUN 88.8M
  • IPO Year
  • CTMX 2015
  • PHUN N/A
  • Fundamental
  • Price
  • CTMX $0.84
  • PHUN $3.79
  • Analyst Decision
  • CTMX Buy
  • PHUN Strong Buy
  • Analyst Count
  • CTMX 6
  • PHUN 3
  • Target Price
  • CTMX $5.77
  • PHUN $13.00
  • AVG Volume (30 Days)
  • CTMX 847.0K
  • PHUN 1.4M
  • Earning Date
  • CTMX 03-10-2025
  • PHUN 03-11-2025
  • Dividend Yield
  • CTMX N/A
  • PHUN N/A
  • EPS Growth
  • CTMX N/A
  • PHUN N/A
  • EPS
  • CTMX 0.16
  • PHUN N/A
  • Revenue
  • CTMX $126,617,000.00
  • PHUN $3,537,000.00
  • Revenue This Year
  • CTMX $22.55
  • PHUN N/A
  • Revenue Next Year
  • CTMX N/A
  • PHUN $93.33
  • P/E Ratio
  • CTMX $5.20
  • PHUN N/A
  • Revenue Growth
  • CTMX 33.66
  • PHUN N/A
  • 52 Week Low
  • CTMX $0.79
  • PHUN $2.85
  • 52 Week High
  • CTMX $5.85
  • PHUN $19.00
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 45.15
  • PHUN 38.74
  • Support Level
  • CTMX $0.82
  • PHUN $3.71
  • Resistance Level
  • CTMX $0.98
  • PHUN $4.04
  • Average True Range (ATR)
  • CTMX 0.06
  • PHUN 0.27
  • MACD
  • CTMX 0.01
  • PHUN -0.06
  • Stochastic Oscillator
  • CTMX 33.58
  • PHUN 14.28

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.

Share on Social Networks: